Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study
Trial ID or NCT#
Status
Purpose
This study evaluates the effectiveness of re-treatment using accelerated schedule of intermittent theta-burst stimulation for treatment-resistant depression. This is an open label study.
Official Title
Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study
Eligibility Criteria
- - Male or female, 18 to 75 years of age. - Able to provide informed consent. - Diagnosed with Major Depressive Disorder (MDD) or bipolar affective disorder 2 and currently experiencing a Major Depressive Episode (MDE). - prior exposure to rTMS - Participants must qualify as "moderate or severe treatment refractory" using the Maudsley staging method. - Participants may continue antidepressant regimen, but must be stable for 6 weeks prior to enrollment in the study. They must maintain that same antidepressant regimen throughout the study duration. - Participants are required to have a stable psychiatrist for the duration of study enrollment.
- - History of MI, CABG, CHF, or other cardiac history - Any neurological conditions - History of epilepsy - OCD - Independent sleep disorder - Autism Spectrum Disorder
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Claudia Tischler, BA
650-498-8535
View on ClinicalTrials.gov